Primary Progresive Ms treatment - Case study 034
Age: 37 Sex: Female Nationality: British
Treatment center: Moscow Date: 05.-26. January 2012
Diagnosis: Primary Progressive Ms
PRE-TREATMENT CONDITION: Physical examination shows stable vital signs. Patient was
diagnosed with Primary Progressive Ms in 2008. Since then, Ms symptoms progressed in severity - vision, hand grip, vertigo
headaches, pain and stiffness in legs. Other symptoms (fatigue, weakness, energy level,
depression) stagnated. No new symptoms occurred. The patient does not use crutches or
wheelchair but has extreme walking problems (right leg) and writing (right hand). Weakness in
limbs is visible. Energy levels are low, even when resting. Blurry vision is almost constant
(probably causes headaches and vertigo). Hand grip is weak in both hands, but much stronger
in the left one. Now after treatment patient story is full of optimisim, and six months after stem cell treatment symptoms have significantly improved.
TREATMENT DATA
PATIENT CONDITION: After stem cell treatment for Primary Progressive Ms, patient had no side effects, feels fatigued,
but not depressed. Initially, she feels that her mood improved significantly. Leg pain and muscle
stiffness reacted very well to physiotherapy (especially lymphatic drainage). The patient feels
that enhancement procedures helped her symptoms. Her mood, energy level, limb weakness,
hand grip and fatigue improved. Headaches, vision problems and vertigo persist (much less
intensity)
FOLLOW - UP #1
Treatment center: Moscow Date: 20. April 2012
Patient condition: 6 months after the treatment, patient shows significant improvements.
Long walks are rarely followed by pain and muscle stiffness. She still has some trouble walking,
but stability is not a great problem anymore. Limb weakness and hand grip improved but she
still cannot write as good as she wants to (but "writing exercises are not a priority") Her vision
is still "blurry". Headaches and vertigo are less frequent than three months ago.
FINAL ASSESSMENT
Based on the patient's evaluation on the levels of improvement of her condition (improvements
of the Ms symptoms are graded 1-10) we can conclude that her overall condition significantly
improved (average rating of 5.60) immediately after stem cell administration. First follow-up
evaluation showed additional improvements in all of her symptoms (average rating of 7.00) as
well as the second follow-up evaluation - final improvement rating of 7.92 which means that the
patient's condition improved 79,2 % by her own assessment.